We are Sorry, This Page doesn't Exist
U.S. IPO Weekly Recap: Despite Sell-Off, 4 IPOs Price With Unicorn Anaplan Up 43%
U.S. IPO Weekly Recap: Despite Sell-Off, 4 IPOs Price With Unicorn Anaplan Up 43%.....»»
U.S. IPO Weekly Recap: IPOs Are Put Through The Ringer With 7 Completed Deals
U.S. IPO Weekly Recap: IPOs Are Put Through The Ringer With 7 Completed Deals.....»»
U.S. IPO Weekly Recap: 3 Healthcare IPOs Trade Flat
U.S. IPO Weekly Recap: 3 Healthcare IPOs Trade Flat.....»»
U.S. IPO Weekly Recap: 3 Small IPOs Price As Tech Gets Taken Out
U.S. IPO Weekly Recap: 3 Small IPOs Price As Tech Gets Taken Out.....»»
U.S. IPO Weekly Recap: 2 Foreign IPOs Price During Short Thanksgiving Week
U.S. IPO Weekly Recap: 2 Foreign IPOs Price During Short Thanksgiving Week.....»»
U.S. IPO Weekly Recap: Gossamer Bio Launches 20-Day IPO, With More IPOs Coming
U.S. IPO Weekly Recap: Gossamer Bio Launches 20-Day IPO, With More IPOs Coming.....»»
U.S. IPO Weekly Recap: 2 Billion-Dollar Biotechs Cap A Mixed Week For Biotech IPOs
U.S. IPO Weekly Recap: 2 Billion-Dollar Biotechs Cap A Mixed Week For Biotech IPOs.....»»
Structuring Your Roth IRA Conversion
If you are approaching retirement with a substantial IRA balance, it might make sense to start structuring annual conversions into a Roth IRA......»»
Google"s Sundar Pichai Grapples With AI Mishaps, Nvidia "Caitlin Clark" Of Stock Market And More: This Week In AI
From Google's Sundar Pichai dealing with AI-related challenges to Cathie Wood's Ark Investment Management trimming its position in a major AI player, here's the weekly AI news recap. read more.....»»
Market Snapshot: Stock futures point higher after Dow, S&P 500 post consecutive losing weeks
Stock-index futures rise Monday, signaling a positive start for Wall Street after back-to-back weekly declines for the Dow Jones Industrial Average and the S&P 500......»»
JetBlue"s New York to London Heathrow flights to begin in August
JetBlue said its JFK to London Gatwick Airport flights will start on September 29, and its London service from Boston will start in summer 2022......»»
Bond Report: 10-year Treasury yields tilt lower, with stocks set to face pressure to start the week
U.S. government bond yields edge back Monday morning after a period in which the 30-year Treasury bond put in its largest weekly rate rise in about two months amid rising inflation fears......»»
A Look At Upcoming IPOs For The Week
With the start of a new week comes the excitement surrounding a new set of companies looking to make an impact throu.....»»
Metals Stocks: Gold prices jump to start May trade amid subdued dollar, bond yields
Gold futures climb sharply on Monday as weakness in the dollar and subdued yields for government bonds help to revive some buying in bullion after a weekly drop skid notched on Friday......»»
OSU, Children’s start to see fruits of research labor
At long last, successes are piling up. The two Columbus institutions have generated not only revenue, but IPOs, several acquisitions, job-creating startups and an FDA-approved gene therapy that has normally non-effusive scientists using the term cure......»»
Five things you need to know today, and a couple of Red Sox memories
Good morning, Boston, and congratulations Hideki Matsuyama. Here are the five most important things you need to know to help start your busy business day. Tale of two Amazons The cover story in the latest Weekly Edition, from Greg Ryan, examin.....»»
S&P crosses 4,000 for first time, Nasdaq soars 1.76%
Tech stocks got off to a strong start in the second quarter even as weekly jobless claims rose......»»
Nasdaq jumps, S&P crosses 4,000 for first time to start 2Q
Tech stocks got off to a strong start in the second quarter even as weekly jobless claims rose......»»
Redwood City-based Biomea Fusion, Menlo Park-based Akoya Biosciences plan IPOs
One has a product already on the market; the other doesn't expect to be start its first clinical trial until the second half of this year. That didn't stop them from testing the public markets......»»
Two life sciences startups file IPOs amid market jitters
One has a product already on the market; the other doesn't expect to be start its first clinical trial until the second half of this year. That didn't stop them from testing the public markets......»»